Inflammatory Bowel Disease

被引：86

作者：

Bruner, Lia Pierson ^{[1
]}

White, Anna Marie ^{[2
]}

Proksell, Siobhan ^{[3
]}

机构：

[1] Augusta Univ, Univ Georgia Med Partnership, UGA Hlth Sci Campus,Russell Hall,Room 235K,1425 Pr, Athens, GA 30602 USA

[2] Univ Pittsburgh, UPMC Shadyside Hosp, Sch Med, North Tower,Room 307,5230 Ctr Ave, Pittsburgh, PA 15232 USA

[3] Univ Miami, Miller Sch Med, Div Digest Hlth & Liver Dis, 1120 Northwest 14th St,Room 1184, Miami, FL 33136 USA

来源：

PRIMARY CARE | 2023年 / 50卷 / 03期

关键词：

Inflammatory bowel disease; Crohn disease; Ulcerative colitis; Chronic diarrhea; Immunosuppression; ADVISORY-COMMITTEE; UNITED-STATES; IMMUNIZATION PRACTICES; UPDATED RECOMMENDATIONS; ADULTS; CANCER; RISK; CARE; PREVALENCE; PREVENTION;

D O I：

10.1016/j.pop.2023.03.009

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

CD and UC, both forms of IBD, are seen in approximately 1% of the population and are typically characterized by chronic diarrhea (with or without bleeding), abdominal pain, and weight loss. The diagnosis is based on history, physical examination, laboratory studies, and endoscopic evaluation with biopsy. EIMs may coincide with or precede IBD diagnosis. Pharmacologic treatments have markedly advanced in the past decade, resulting in improved outcomes. Chronic inflammation from IBD as well as treatments that induce immunosuppression increases rates for certain conditions, making collaboration between GI and primary care an integral part of care for the patient with IBD.

引用

页码：411 / 427

页数：17

共 31 条

[1] Are Patients with Inflammatory Bowel Disease on Chronic Immunosuppressive Therapy at Increased Risk of Cervical High-grade Dysplasia/Cancer? A Meta-analysis [J].

Allegretti, Jessica R. ;

Barnes, Edward L. ;

Cameron, Anna .

INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) :1089-1097

[2]

Anderson TC, 2022, MMWR-MORBID MORTAL W, V71, P80, DOI 10.15585/mmwr.mm7103a2

[3] Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment [J].

Axelrad, Jordan E. ;

Lichtiger, Simon ;

Yajnik, Vijay .

WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (20) :4794-4801

[4] Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis [J].

Barberio, Brigida ;

Zamani, Mohammad ;

Black, Christopher J. ;

Savarino, Edoardo, V ;

Ford, Alexander C. .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (05) :359-370

[5] Optimizing Immunization Strategies in Patients with IBD [J].

Caldera, Freddy ;

Ley, Dana ;

Hayney, Mary S. ;

Farraye, Francis A. .

INFLAMMATORY BOWEL DISEASES, 2021, 27 (01) :123-133

[6] Inflammatory Bowel Disease and Cardiovascular Diseases [J].

Chen, Bing ;

Collen, Lauren V. ;

Mowat, Craig ;

Isaacs, Kim L. ;

Singh, Siddharth ;

Kane, Sunanda V. ;

Farraye, Francis A. ;

Snapper, Scott ;

Jneid, Hani ;

Lavie, Carl J. ;

Krittanawong, Chayakrit .

AMERICAN JOURNAL OF MEDICINE, 2022, 135 (12) :1453-1460

[7] Venous thromboembolism in inflammatory bowel disease [J].

Cheng, Kimberly ;

Faye, Adam S. .

WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (12) :1231-1241

[8] Exercise in patients with inflammatory bowel diseases: current perspectives [J].

Engels, Michael ;

Cross, Raymond K. ;

Long, Millie D. .

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 :1-11

[9] ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease [J].

Farraye, Francis A. ;

Melmed, Gil Y. ;

Lichtenstein, Gary R. ;

Kane, Sunanda V. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (02) :241-258

[10]

Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1

← 1 2 3 4 →